Literature DB >> 32687943

Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting.

Michelle D Williams1, Ron A DeLellis2, Lori A Erickson3, Ruta Gupta4, Sarah J Johnson5, Kaori Kameyama6, Sonali Natu7, Tony Ng8, Aurel Perren9, Nancy D Perrier10, Raja R Seethala11, Anthony J Gill12.   

Abstract

Standardized pathologic reporting for cancers improves patient care and prognostic determination. However, access in many countries is limited. To address this issue, the International Collaboration on Cancer Reporting (ICCR), a not-for-profit organization, has the mission to develop and disseminate standardized data sets for global use. Within endocrine organs, the parathyroid gland has rarely been included in formal pathologic data sets. Utilizing an expert international panel of eleven members, an evidence-based data set was developed for parathyroid carcinoma and atypical parathyroid neoplasms. This data set consists of sixteen core (required) elements viewed as essential for documentation of these conditions. Characterizing parathyroid carcinomas and atypical neoplasms begins with correlative clinical information, the operative procedure, specimens submitted, and site of the disease. The pathologic features essential to document include parathyroid weight, size, classification, and, when a carcinoma, the tumor grade. Histologic grade of parathyroid carcinoma incorporates other core elements including necrosis, mitotic count, perineural invasion, and lymphovascular invasion. Documenting the extent of disease locally into adjacent organs, regionally, and distally is critical for staging. Pathologic staging is now included as part of the American Joint Committee on Cancer 8th edition and is included in this data set. Ancillary studies should be recorded when performed as noncore elements. Standardized pathologic data sets for endocrine organs including the parathyroid gland are now available through the ICCR website. These essential resources enhance international standardization for documenting these rare tumors for both patient care and future guidelines.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical parathyroid neoplasm; ICCR; Parathyroid carcinoma; Pathology synoptic report

Year:  2020        PMID: 32687943     DOI: 10.1016/j.humpath.2020.07.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

Review 1.  Overview of the 2022 WHO Classification of Parathyroid Tumors.

Authors:  Lori A Erickson; Ozgur Mete; C Christofer Juhlin; Aurel Perren; Anthony J Gill
Journal:  Endocr Pathol       Date:  2022-02-17       Impact factor: 3.943

Review 2.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

Review 3.  Intraoperative assessment of parathyroid pathology in sporadic primary hyperparathyroidism: an institutional experience.

Authors:  Nicole A Cipriani; Krzysztof Glomski; Peter M Sadow
Journal:  Hum Pathol       Date:  2022-02-20       Impact factor: 3.526

Review 4.  Parathyroid Carcinoma All-In-One, a Rare Life-Threatening Case With Multiple Systemic Manifestations: Case Report and Review of the Literature.

Authors:  Lorenzo Zelano; Pietro Locantore; Carlo Antonio Rota; Caterina Policola; Andrea Corsello; Esther Diana Rossi; Vittoria Rufini; Luca Zagaria; Marco Raffaelli; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

5.  Multiglandular Parathyroid Disease.

Authors:  Grzegorz Kowalski; Grzegorz Buła; Adam Bednarczyk; Agata Gawrychowska; Jacek Gawrychowski
Journal:  Life (Basel)       Date:  2022-08-22

6.  A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.

Authors:  Ying C Henderson; Abdallah S R Mohamed; Anastasios Maniakas; Yunyun Chen; Reid T Powell; Shaohua Peng; Maria Cardenas; Michelle D Williams; Diana Bell; Mark E Zafereo; Rui Jennifer Wang; Steve E Scherer; David A Wheeler; Maria E Cabanillas; Marie-Claude Hofmann; Faye M Johnson; Clifford C Stephan; Vlad Sandulache; Stephen Y Lai
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

7.  Dataset for Pathology Reporting of Colorectal Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Authors:  Maurice B Loughrey; Fleur Webster; Mark J Arends; Ian Brown; Lawrence J Burgart; Chris Cunningham; Jean-Francois Flejou; Sanjay Kakar; Richard Kirsch; Motohiro Kojima; Alessandro Lugli; Christophe Rosty; Kieran Sheahan; Nicholas P West; Richard H Wilson; Iris D Nagtegaal
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.